Lundbeck to present positive pipeline data at American Academy of Neurology (AAN) Annual Meeting

Contributed by: PR Newswire

Tags

H.-Lundbeck-A/S

More Like This

Lundbeck to present new data on bexicaserin at upcoming congress, highlighting long-term impact on seizure frequency in patients with rare epilepsy

Lundbeck to present comprehensive new bexicaserin dataset in patients with rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting

Lundbeck announces positive Phase 2 long-term data for bexicaserin in rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting

Latest data on long-term, real-world treatment with lecanemab will be presented at the AD/PD™ 2026 congress

Lundbeck showcases new clinical migraine data, including long-term preventive effectiveness of Vyepti® (eptinezumab) in patients severely impacted by migraine

Lecanemab four-year efficacy and safety data to be presented at AAIC 2025

New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress

Long-term treatment data for lecanemab to be presented at AAIC 2024